Citation Impact
Citing Papers
Early G1 Cyclin-Dependent Kinases as Prognostic Markers and Potential Therapeutic Targets in Esophageal Adenocarcinoma
2011
Tumour-targeted nanomedicines: principles and practice
2008
Psychological Stress and Disease
2007 Standout
Changes in the immune system in depression and dementia: causal or co‐incidental effects?
2001
No health without mental health
2007 Standout
Engineering precision nanoparticles for drug delivery
2020 Standout
NRF2 and KEAP1 mutations: permanent activation of an adaptive response in cancer
2009 Standout
Accumulation of sub-100 nm polymeric micelles in poorly permeable tumours depends on size
2011 Standout
The Concept of Synthetic Lethality in the Context of Anticancer Therapy
2005 StandoutNobel
Is Caregiving Hazardous to One's Physical Health? A Meta-Analysis.
2003 Standout
Role for the p53 homologue p73 in E2F-1-induced apoptosis
2000 StandoutNatureNobel
The role of porphyrin chemistry in tumor imaging and photodynamic therapy
2010 Standout
Progression to AIDS
1999
Increasing Condom Use by Undermining Perceived Invulnerability to HIV
2002
Cancer nanotechnology: The impact of passive and active targeting in the era of modern cancer biology
2013 Standout
Image-guided and passively tumour-targeted polymeric nanomedicines for radiochemotherapy
2008
Clinical development and potential of photothermal and photodynamic therapies for cancer
2020 Standout
Polymer-drug conjugates: Recent development in clinical oncology
2008
Prodrug Strategies in Anticancer Chemotherapy
2007
Production and Characterization of γ-Polyglutamic Acid Nanoparticles for Controlled Anticancer Drug Release
2008
Paclitaxel poliglumex for ovarian cancer
2011
HIV and depression: 2008 review and update
2008
Nanoparticle therapeutics: an emerging treatment modality for cancer
2008 Standout
Fluorescence-activated cell sorting of transfected cells
1997 StandoutNobel
Nano based drug delivery systems: recent developments and future prospects
2018 Standout
Role of the retinoblastoma protein in the pathogenesis of human cancer.
1997 StandoutNobel
Social Relationships and Mortality Risk: A Meta-analytic Review
2010 Standout
Binding of pRB to the PHD Protein RBP2 Promotes Cellular Differentiation
2005 StandoutNobel
To exploit the tumor microenvironment: Passive and active tumor targeting of nanocarriers for anti-cancer drug delivery
2010 Standout
Progression to AIDS, a clinical AIDS condition and mortality: psychosocial and physiological predictors
2002
The regulation of E2F by pRB-family proteins
1998 Standout
PEGylation as a strategy for improving nanoparticle-based drug and gene delivery
2015 Standout
Design and fabrication of magnetic nanoparticles for targeted drug delivery and imaging
2009 Standout
Single-molecule force spectroscopy: optical tweezers, magnetic tweezers and atomic force microscopy
2008 Standout
Mechanisms of drug combinations: interaction and network perspectives
2009 Standout
Does changing behavioral intentions engender behavior change? A meta-analysis of the experimental evidence.
2006 Standout
Analysis of comptothecin resistance in yeast: relevance to cancer therapy
1998
Targeting the Raf-MEK-ERK mitogen-activated protein kinase cascade for the treatment of cancer
2007 Standout
Meta-Analysis of the Relationship Between HIV Infection and Risk for Depressive Disorders
2001 Standout
Topoisomerase II Is Required for Mitoxantrone to Signal Nuclear Factor κB Activation in HL60 Cells
2000
The Benefits of Frequent Positive Affect: Does Happiness Lead to Success?
2005 Standout
Psychological Stress and Cardiovascular Disease
2008 Standout
The Rb/E2F pathway: expanding roles and emerging paradigms
2000 Standout
Poly(ethylene glycol) in Drug Delivery: Pros and Cons as Well as Potential Alternatives
2010 Standout
Application of Nanotechnology in Cancer Therapy and Imaging
2008
Nanomaterial-based therapeutics for antibiotic-resistant bacterial infections
2020 Standout
Stress-induced immune dysfunction: implications for health
2005 Standout
Growth Regulation by the E2F and DP Transcription Factor Families
1998
Hybrid nanoparticles for combination therapy of cancer
2015
Camptothecin Sensitivity Is Mediated by the Pleiotropic Drug Resistance Network in Yeast
1997
Antitumour drugs impede DNA uncoiling by topoisomerase I
2007 Nature
Chromatin remodeller SMARCA4 recruits topoisomerase 1 and suppresses transcription-associated genomic instability
2016 StandoutNobel
The AID Dilemma
2012 StandoutNobel
Liposomal drug delivery systems: From concept to clinical applications
2012 Standout
Association of psychosocial risk factors with risk of acute myocardial infarction in 11 119 cases and 13 648 controls from 52 countries (the INTERHEART study): case-control study
2004 Standout
Chronic Work Stress and Marital Dissolution Increase Risk of Posttrial Mortality in Men From the Multiple Risk Factor Intervention Trial
2002
Topoisomerase I suppresses genomic instability by preventing interference between replication and transcription
2009
Drug targeting to tumors: Principles, pitfalls and (pre-) clinical progress
2011
Topoisomerase I inhibitors: camptothecins and beyond
2006 Standout
The history and future of targeting cyclin-dependent kinases in cancer therapy
2015 Standout
Immunogenic cell death and DAMPs in cancer therapy
2012 Standout
Fluorine in Pharmaceutical Industry: Fluorine-Containing Drugs Introduced to the Market in the Last Decade (2001–2011)
2013 Standout
Pessimism correlates with leukocyte telomere shortness and elevated interleukin-6 in post-menopausal women
2008 StandoutNobel
HEALTH PSYCHOLOGY: Mapping Biobehavioral Contributions to Health and Illness
1999
FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer
2011 Standout
DNA Topoisomerase I Inhibitors: Chemistry, Biology, and Interfacial Inhibition
2009 Standout
Decrease in topoisomerase I is responsible for activation-induced cytidine deaminase (AID)-dependent somatic hypermutation
2011 StandoutNobel
E2F-1 Cooperates with Topoisomerase II Inhibition and DNA Damage To Selectively Augment p53-Independent Apoptosis
1997
Inactivation of p53 increases the cytotoxicity of camptothecin in human colon HCT116 and breast MCF-7 cancer cells.
1997 StandoutNobel
Degradable Controlled-Release Polymers and Polymeric Nanoparticles: Mechanisms of Controlling Drug Release
2016 Standout
Nanotechnology for Multimodal Synergistic Cancer Therapy
2017 Standout
Nanotechnology for Cancer Therapy Based on Chemotherapy
2018
Expression of Dominant-Negative Mutant DP-1 Blocks Cell Cycle Progression in G1
1996
Reactive Oxygen Species (ROS)-Based Nanomedicine
2019 Standout
The roles of dispositional optimism and pessimism in hiv disease progression
2004
Investigational nanomedicines in 2016: a review of nanotherapeutics currently undergoing clinical trials
2016
Stigma as a Fundamental Cause of Population Health Inequalities
2013 Standout
Analysis of nanoparticle delivery to tumours
2016 Standout
Fetal Alz-50 Clone 1 Interacts with the Human Orthologue of the Kelch-like Ech-Associated Protein
2004
Challenges Associated With Increased Survival Among Parents Living With HIV
2001
Lapatinib: Current Status and Future Directions in Breast Cancer
2006
Reactive oxygen species generating systems meeting challenges of photodynamic cancer therapy
2016 Standout
Neuropsychiatric manifestations of HIV infection and AIDS
2005
Progress in Nanomedicine: Approved and Investigational Nanodrugs.
2017
Metastatic pancreatic cancer: Is gemcitabine still the best standard treatment? (Review)
2010
Clinical Translation of Nanomedicine
2015
Works of Devon Evans being referenced
Psychosocial Predictors of High-Risk Sexual Behavior Among HIV-Negative Homosexual Men
1993
Phase I/II study of trastuzumab, paclitaxel, cisplatin and radiation for locally advanced, HER2 overexpressing, esophageal adenocarcinoma
2006
Increased Camptothecin Toxicity Induced in Mammalian Cells Expressing Saccharomyces cerevisiae DNA Topoisomerase I
1998
Paclitaxel Poliglumex (PPX-Xyotax) and Concurrent Radiation for Esophageal and Gastric Cancer
2006
Paclitaxel Poliglumex, Temozolomide, and Radiation for Newly Diagnosed High-grade Glioma
2013
Lapatinib/Gemcitabine and Lapatinib/Gemcitabine/Oxaliplatin
2008
Isolation of Two Novel cDNAs Whose Products Associate with the Amino Terminus of the E2F1 Transcription Factor
1996
Severe life stress as a predictor of early disease progression in HIV infection
1997
GW572016, gemcitabine and GW572016, gemcitabine, oxaliplatin, a two-stage, phase I study for advanced pancreaticobiliary cancer
2006
Expression of a deletion mutant of the E2F1 transcription factor in fibroblasts lengthens S phase and increases sensitivity to S phase-specific toxins.
1995